MACOM Reports Fiscal Third Quarter 2026 Financial Results

MACOM reported fiscal Q3 revenue of $342.2M (+35.8% YoY) and GAAP net income of $100.7M ($1.28 diluted EPS), up from $36.5M ($0.48) a year earlier, with gross margin improving to 58.3% (+300 bps YoY). Operating income rose to $77.1M (22.5% of revenue) from $37.7M (14.9%); on a non-GAAP basis, adjusted diluted EPS was $1.40. For fiscal Q4 (ending Oct. 2, 2026), the company guided revenue to $415M–$425M and adjusted diluted EPS to $1.97–$2.03, implying continued margin and earnings expansion.

Analysis

This print is more important for what it says about end-market mix than for the beat itself: MACOM is showing that higher-value content is taking share in data center and defense, which tends to carry through to peers with similar exposure. If that mix persists, the second-order winner is less the broad semi index and more the subset of compound/RF names with tight supply and leverage to optical interconnect, while slower-growth telecom/industrial names risk looking like margin laggards even if unit demand is stable.

The biggest near-term risk is that the market anchors on the optimistic forward margin guide and ignores how much of the current EPS is helped by financial items and a very low tax rate. Over 1-3 months, the key falsifier is whether the next channel check confirms real bookings conversion rather than inventory restocking; if backlog or book-to-bill softens, the multiple should compress quickly because the stock is trading as a growth compounder, not a cyclical rebound.

Contrarian read: this may be less a “beat” than an early-cycle quality upgrade. The balance-sheet cleanup and capex/investment posture reduce financial fragility, but they also set up 6-18 month execution risk if the company has to fund growth before revenue is fully absorbed. That makes the stock attractive on dips, but not blindly chaseable after an earnings gap unless management commentary confirms the guide is demand-led rather than supply-driven.

For credit markets, the cleaner balance sheet and lower refinancing risk are a positive for MACOM’s paper, but the real spread story would be tighter only if free cash flow stays above capex and working-capital needs into the next two quarters.

Key Decisions for Investors

• Long MTSI on the post-earnings pullback rather than strength; target a 10-15% upside over 1-3 months if the market starts pricing the raised margin guide as durable rather than transitory.
• Pair: long MTSI / short MCHP for the next 6-10 weeks. Thesis is better operating leverage and cleaner demand mix at MTSI versus more value-trap risk in slower analog exposure; stop if MTSI guide is revised down or MCHP prints a book-to-bill inflection.
• Watch IQEPF as a second-order beneficiary only if MACOM commentary later confirms meaningful supply-chain qualification gains. Treat as an alert, not a trade, until there is evidence of incremental revenue contribution.
• For options, prefer selling put spreads on MTSI into elevated post-earnings volatility rather than buying calls outright; the setup favors upside grind, but valuation can re-rate only if the next two quarters confirm bookings and FCF conversion.